← Evidence map

ReviewDrugs2017

Daratumumab: A Review in Relapsed and/or Refractory Multiple Myeloma.

Hannah A BlairPubMed ↗Publisher ↗

No numbers read from the abstract.

20 papers cite it

2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
this paperpooled ittrialcites it

The trial

NCT07021677phase 218 enrolled2023
Full record →Abstract, authors, funding and every citing paper · PMID 29127588